Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Apr 4, 2024
Femasys is committed to providing women with revolutionary healthcare products: CEO
AlphaStreet
Read ↗
Mar 20, 2024
FemaSeed: A Breakthrough Solution Proving Promise in Overcoming Infertility Challenges
CSIMarket
Read ↗
Mar 20, 2024
FemaSeed Shows Positive Results for Infertility Treatment
Contemporary OB/GYN
Read ↗
Mar 20, 2024
Femasys Announces Positive Topline Data from Pivotal Trial for FDA-Cleared FemaSeed
Femasys IR
Read ↗
Mar 20, 2024
Femasys Discloses Positive Data from FemaSeed Trial
The Wall Street Journal
Read ↗
Mar 6, 2024
Femasys Completes First In-Office Commercial Procedure with FDA-Cleared FemaSeed
GlobeNewswire / Femasys
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.